Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ 1/6/2025

    The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.

  2. Why Compliance-Driven CDMOs Win Sponsor Contracts 2/5/2026

    Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.

  3. Flexible Cell Culture Media For High Titer Production Of AAV In HEK 293 2/4/2026

    To maximize the results of viral titer and full capsids, it's necessary to undertake systematic process development and optimization of AAV production. The choice of cell culture medium is foundational.

  4. Evaluating Antibody Fragment Purification Using VH3 Resin 5/22/2026

    Explore how VH-domain targeting enables efficient purification of VH3 antibody fragments and bispecific formats, with strong recoveries and flexible wash conditions that support improved purity.

  5. Measure And Control In-Line Protein Concentration 1/22/2026

    Streamline protein and antibody purification with an automated TFF system featuring real-time, in-line concentration measurement for enhanced accuracy, reliability, and cGMP compliance.

  6. Tailored Approach Supports Bladder Cancer Breakthrough 3/5/2026

    Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.

  7. Enhancing AAV Production Performance And Economics 3/24/2026

    Enzymatically produced dbDNA offers safer, faster, and more scalable AAV manufacturing by reducing costs, improving full capsid yields, and enabling high‑fidelity, bacteria‑free DNA production.

  8. Expansion Of Human Umbilical Cord-Derived MSCs 7/18/2025

    Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.

  9. Single-Use Assembly Capabilities To Keep Pace With Biopharma Dynamics 3/17/2025

    Discover how a vendor-independent partner assists global life science companies and CDMOs with innovative single-use technologies to mitigate risks and ensure uninterrupted manufacturing.

  10. Effective Strategies To Minimize Product Loss During Fill Finish 5/11/2026

    Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.